Skip to main content
Clinical Trials/DRKS00025791
DRKS00025791CompletedNot Applicable

Accelerated long-term forgetting in Multiple sclerosis patients with little disability

Carl von Ossietzky Universität OldenburgAbteilung für Neurologie0 sites64 target enrollmentStarted: July 5, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
64

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • Diagnosis of multiple sclerosis according to the revised McDonald criteria (Thompson et al., 2018), all subgroups (relapsing remitting multiple sclerosis (RRMS), secondary progressive multiple sclerosis (SPMS) and primary progressive multiple sclerosis (PPMS) will be eligible).
  • Patients must be capable of being informed and must be able to sufficiently reflect on the decision to participate in the study; this criterion will be checked before the information is provided.
  • Prerequisite for participation in the study is German as native language.

Exclusion Criteria

  • Signs of depression (BDI > 20)
  • - Taking medications that modify memory performance (e.g., anticholinergics for
  • treatment of bladder weakness)
  • - Medical conditions beyond multiple sclerosis that may impair brain function.
  • - A severe physical disability with an EDSS score >= 6, equivalent to a motor
  • Disability resulting in a walking distance less than 100m.
  • Presence of a psychiatric or neurological disorder.
  • Regular use of medications that interact with CNS function.

Investigators

Sponsor
Carl von Ossietzky Universität OldenburgAbteilung für Neurologie

Similar Trials

Accelerated long-term forgetting in... | Clinical Trial